CIBC Global Technology (CIB496)
46.72
-0.54 (-1.14%)
CAD |
Jun 30 2022
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
2.38% | 332.13M | 0.00% | 133.0% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
-4.432M | -21.72% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The fund seeks to provide long-term growth through capital appreciation by investing globally, primarily in companies that are involved in the development, application, production, or distribution of scientific and technology-based products and services. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | CIB496 |
Equity Style | Large Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Global Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | Canadian Imperial Bank of Commerce |
Prospectus Benchmark Index | |
MSCI World Information Tech CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Michal Marszal | 4.90 yrs |
Craig Jerusalim | 3.09 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
70
-4.432M
-534.39M
Category Low
4.142B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of June 30, 2022
Performance Versus Category
As of June 30, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 30, 2022.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Microsoft Corp | 8.94% | 259.58 | 1.07% |
Alphabet Inc Class A | 7.12% | 2174.75 | -0.21% |
Apple Inc | 6.43% | 138.93 | 1.62% |
Novartis AG
|
4.51% | -- | -- |
UnitedHealth Group Inc | 4.25% | 517.40 | 0.73% |
Mastercard Inc Class A | 4.19% | 318.24 | 0.87% |
Sanofi SA
|
4.12% | -- | -- |
T-Mobile US Inc | 4.04% | 136.81 | 1.69% |
Medtronic PLC | 3.95% | 91.38 | 1.82% |
Takeda Pharmaceutical Co Ltd
|
3.88% | -- | -- |
Basic Info
Investment Strategy | |
The fund seeks to provide long-term growth through capital appreciation by investing globally, primarily in companies that are involved in the development, application, production, or distribution of scientific and technology-based products and services. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | CIB496 |
Equity Style | Large Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Global Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | Canadian Imperial Bank of Commerce |
Prospectus Benchmark Index | |
MSCI World Information Tech CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Michal Marszal | 4.90 yrs |
Craig Jerusalim | 3.09 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (6-30-22) | 0.00% |
30-Day SEC Yield | -- |
7-Day SEC Yield (4-29-09) | Upgrade |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 0.0406 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of May 31, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 12/11/1995 |
Last Annual Report Date | 12/31/2021 |
Last Prospectus Date | -- |
Share Classes | |
CIB158 | Fee-based Advice |
CIB159 | -- |
CIB896 | -- |
Attributes | |
Enhanced Index Fund | No |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan |
|
Socially Responsible Fund | No |